Abstract submission ends 16-Dec-24!!!
〰️
Abstract submission ends 16-Dec-24!!! 〰️
The US Mid-Atlantic Organizing Committee and the Scientific Steering Committee of the Americas Region are planning an exciting program that will bring together scientists, pediatric oncologists and a wide range of clinical subspecialists, students, early-stage investigators, and advocates from around the world.
The meeting will afford unique opportunities to exchange ideas and share laboratory and clinical innovations that will enable a greater understanding of the pathogenesis of neuroblastoma and evolving treatments. This is key to accelerating and advancing our shared goal of developing more effective and less toxic therapies for our patients with neuroblastoma.
ANR 2025 will be ideal for making new and reinforcing old friendships while in Washington, DC. The region is home to the National Cancer Institute, NIH, FDA, DOD and the leadership that directs much of the US biomedical research enterprise.
SUMMARY of Relevant information
VENUE
The Westin Washington, DC Downtown
Renaissance Washington, DC Downtown Hotel
999 9th St NW, Washington, DC 20001, United States
DATES
From 25th to 28th May 2025
ACCOMODATION
Kenes Group will obtain special accommodation rates for ANR 2025 participants. Please visit the accommodation page periodically.
Registration is not available yet (expected Sept24), early bird ends on 28th February 2025
Abstract submission has been open since May 2024. Deadline: 16th December 2024